A Study to Assess the Safety, Tolerability and Efficacy of ION775
NCT07604974 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2026-05-22
Summary
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Conditions
Interventions
- DRUG
-
ION775
ION775 will be administered by SC injection.
Sponsors & Collaborators
-
Ionis Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-31
- Primary Completion
- 2027-09-30
- Completion
- 2028-03-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese
NCT06567327 ·Status: COMPLETED ·Phase: PHASE1
-
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
NCT06471543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
NCT01878474 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, First Time in Humans Study of NST-1024
NCT04630366 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3561774 in Participants With Dyslipidemia
NCT04644809 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
NCT01044108 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
NCT03254446 ·Status: UNKNOWN ·Phase: PHASE3
-
An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients
NCT00239967 ·Status: COMPLETED ·Phase: PHASE3
-
Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity
NCT05406115 ·Status: COMPLETED ·Phase: PHASE1
-
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
NCT01874366 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)
NCT03361501 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)
NCT03398005 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
NCT05677867 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
NCT07437079 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
NCT01614782 ·Status: TERMINATED ·Phase: PHASE1
-
A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients
NCT02476019 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
NCT01968720 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
NCT01749878 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
NCT02958085 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
NCT06049329 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
NCT07153172 ·Status: RECRUITING ·Phase: PHASE1
-
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05841238 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
NCT00748605 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
NCT06064006 ·Status: COMPLETED ·Phase: PHASE2